Stereotactic radiation controls early stage lung cancer
Melanoma survivors at higher risk of other cancers
Cladribine and fludarabine equally helpful for progressive CLL
More frequent surveillance reduces colon cancer risk in Lynch syndrome families
Radiation can be avoided in early Hodgkin's lymphoma
WASHINGTON (Reuters) - The U.S. government needs to step up funding for cancer research, which has stagnated this decade, as part of an effort to make beating cancer a national priority, a presidential advisory panel said on Thursday.
The three-member panel that advises President George W. Bush on cancer-related matters issued a report detailing "troubling trends" including insufficient funding for research into new ways to treat and prevent cancer.
The report noted that the U.S. population is getting older and becoming increasingly sedentary, a recipe for more cancer cases; more than a fifth of the population still smokes; the health care system is fragmented; and policymakers have failed to grasp the urgency of making progress against cancer.
The panel urged improved coordination of efforts against cancer, better access to health care for Americans as about 45.7 million people have no health insurance, and further efforts to curb tobacco use.
"Use of clinical trials, basic research, clinical research -- we must have adequate funding for that, and we will continue to push for that," Dr. LaSalle Leffall of Howard University in Washington, who heads the President's Cancer Panel, said in a telephone interview.
U.S. biomedical research "is being starved of funding at a pivotal juncture," according to the report.
Funding for the National Cancer Institute, part of the U.S. government's research-supporting National Institutes of Health, nearly doubled from 1998 to 2003, but has stagnated since.
NCI funding since 2003 has declined 16.5 percent when accounting for inflation, the American Cancer Society said. The NCI received $4.8 billion in the 2008 fiscal year.
This means fewer research grants are made and those that are awarded provide less funding than requested by researchers, forcing scientific projects to be scaled back, the American Cancer Society said. Fewer clinical trials are being started and fewer patients are being enrolled in cutting-edge studies than just a few years ago, the group said.
Funding for a variety of programs in the United States may be uncertain over the next year, with the federal government committing hundreds of billions of dollars to bail out the financial industry and stimulate the economy.
About 565,000 Americans are expected to die this year from various forms of cancer and about 1.4 million are expected to be diagnosed with cancer.
Cyclist and testicular cancer survivor Lance Armstrong also serves on the panel.
Copyright © 2008 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.